Publicaciones en colaboración con investigadores/as de Hospital Vall d'Hebron (17)

2024

  1. Experience with the ACURATE neo and neo2 transcatheter aortic valves in Spain. The PRECISA (PRospective Evaluation Complementing Investigation with ACURATE devices) registry

    Catheterization and Cardiovascular Interventions, Vol. 103, Núm. 6, pp. 1015-1022

2023

  1. Genome-based epidemiology and antimicrobial resistance of Neisseria gonorrhoeae in Spain: A prospective multicentre study

    Journal of the European Academy of Dermatology and Venereology, Vol. 37, Núm. 12, pp. 2575-2582

2020

  1. Macrophages promote endothelial-to-mesenchymal transition via MT1-MMP/ TGFβ1 after myocardial infarction

    eLife, Vol. 9, pp. 1-30

  2. Recommendations of the Spanish Antibiogram Committee (COESANT) for selecting antimicrobial agents and concentrations for in vitro susceptibility studies using automated systems

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 38, Núm. 4, pp. 182-187

2019

  1. The impact of culturing the organ preservation fluid on solid organ transplantation: A prospective multicenter cohort study

    Open Forum Infectious Diseases, Vol. 6, Núm. 6

2018

  1. Impact of co-infection by hepatitis C virus on immunological and virological response to antiretroviral therapy in HIV-positive patients

    Medicine (United States), Vol. 97, Núm. 38

  2. Low-level viremia is associated with clinical progression in HIV-infected patients receiving antiretroviral treatment

    Journal of Acquired Immune Deficiency Syndromes, Vol. 78, Núm. 3, pp. 329-337

2017

  1. Simplification to dual therapy (atazanavir/ritonavir1lamivudine) versus standard triple therapy [atazanavir/ritonavir1two nucleos(t)ides] in virologically stable patients on antiretroviral therapy: 96 week results from an open-label, non-inferiority, randomized clinical trial (SALT study)

    Journal of Antimicrobial Chemotherapy, Vol. 72, Núm. 1, pp. 246-253

2015

  1. Dual treatment with atazanavir-ritonavir plus lamivudine versus triple treatment with atazanavir-ritonavir plus two nucleos(t)ides in virologically stable patients with HIV-1 (SALT): 48 week results from a randomised, open-label, non-inferiority trial

    The Lancet Infectious Diseases, Vol. 15, Núm. 7, pp. 775-784

  2. Dual treatment with lopinavir-ritonavir plus lamivudine versus triple treatment with lopinavir-ritonavir plus lamivudine or emtricitabine and a second nucleos(t)ide reverse transcriptase inhibitor for maintenance of HIV-1 viral suppression (OLE): A randomised, open-label, non-inferiority trial

    The Lancet Infectious Diseases, Vol. 15, Núm. 7, pp. 785-792

2014

  1. A Mouse Model Uncovers LKB1 as an UVB-Induced DNA Damage Sensor Mediating CDKN1A (p21 WAF1/CIP1 ) Degradation

    PLoS Genetics, Vol. 10, Núm. 10

2013

  1. Increase in gonorrhoea among very young adolescents, Catalonia, Spain, January 2012 to June 2013

    Eurosurveillance, Vol. 18, Núm. 33

  2. Lkb1 Loss Promotes Tumor Progression of BRAFV600E-Induced Lung Adenomas

    PLoS ONE, Vol. 8, Núm. 6

2012

  1. Imbalance of neurotrophin receptor isoforms TrkB-FL/TrkB-T1 induces neuronal death in excitotoxicity

    Cell Death and Disease, Vol. 3, Núm. 1

  2. Protein kinase C (PKC)ζ-mediated Gα q stimulation of ERK5 protein pathway in cardiomyocytes and cardiac fibroblasts

    Journal of Biological Chemistry, Vol. 287, Núm. 10, pp. 7792-7802

2009

  1. Constitutive COX-2 activity in cardiomyocytes confers permanent cardioprotection. Constitutive COX-2 expression and cardioprotection

    Journal of Molecular and Cellular Cardiology, Vol. 46, Núm. 2, pp. 160-168

2007

  1. Evolution of the antimicrobial resistance of Pseudomonas aeruginosa in Spain: Second National Study (2003)

    Revista Espanola de Quimioterapia, Vol. 20, Núm. 2, pp. 222-229